in this issue
People & Business :: M&A
DSM to Acquire Kensey Nash for $360 Million to Strengthen Biomedical Business
3:14 AM MDT | May 3, 2012 | Deepti Ramesh
DSM says it will acquire Kensey Nash (Exton, PA), a technology-driven biomedical company, for about $360 million. DSM has entered into a definitive agreement with Kensey Nash, under which DSM would acquire all the outstanding shares of common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.5/share in cash for a total enterprise value of about $360 million. The transaction has been approved by DSM’s supervisory board and by Kensey Nash’s board of directors. The agreed price represents a premium...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee